SAFREL
Live / Registered — Registered — Section 8 accepted (as of 11 Sept 2026)
What this means for you
Registered since 09 Jun 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88532787
- Registration number
- 6073034
- Mark type
- Stylized text
- Filed
- 24 Jul 2019
- Published for opposition
- 26 Nov 2019
- Registered
- 09 Jun 2020
Goods and services
- Class 005 — Pharmaceuticals: Full line of over the counter (OTC) pharmaceutical products; full line of dietary and nutritional supplements; all the foregoing excluding pharmaceutical preparations for the treatment of central nervous system diseases and disorders and pharmaceutical preparations for the treatment of epilepsy and seizures
Owner
- Safrel Pharmaceuticals, Bridgewater, NJ, US
- Safrel Pharmaceuticals, Bridgewater, NJ, US
- Safrel Pharmaceuticals, Bridgewater, NJ, US
Prosecution history
- 11 Sept 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 11 Sept 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 05 Sept 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Jul 2026 — TEAS SECTION 8 RECEIVED
- 09 Jun 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
- 01 May 2020 — TTAB RELEASE CASE TO TRADEMARKS
- 06 Apr 2020 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 21 Apr 2020 — POST PUBLICATION AMENDMENT - ENTERED
- 15 Apr 2020 — ASSIGNED TO PETITION STAFF
- 17 Mar 2020 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 19 Dec 2019 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 26 Nov 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Nov 2019 — PUBLISHED FOR OPPOSITION
- 06 Nov 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED